UNIVERSITY OF HOUSTON
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1927-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uh.edu
Clinical Trials
97
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (94 trials with phase data)• Click on a phase to view related trials
Immunometabolism of Exercise
- Conditions
- Cardiorespiratory Fitness and Acute Exercise
- First Posted Date
- 2025-09-23
- Last Posted Date
- 2025-09-23
- Lead Sponsor
- University of Houston
- Target Recruit Count
- 102
- Registration Number
- NCT07188389
- Locations
- 🇺🇸
University of Houston, Houston, Texas, United States
Low Level Light Therapy & Skin Pigmentation
- Conditions
- Dry EyeMeibomian Gland Dysfunction (Disorder)
- First Posted Date
- 2025-09-15
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- University of Houston
- Target Recruit Count
- 40
- Registration Number
- NCT07173530
- Locations
- 🇺🇸
The University of Houston College of Optometry, Houston, Texas, United States
Enhancing Smoking Cessation for African American People Everywhere
- Conditions
- ESCAPE Intervention+NRTquitSTART Intervention+NRTCTRL+NRT
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- University of Houston
- Target Recruit Count
- 300
- Registration Number
- NCT07024992
- Locations
- 🇺🇸
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Shaping Habitual Impulses For a Tobacco-free Style
- Conditions
- ST+ABRST+SHAMST-only
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- University of Houston
- Target Recruit Count
- 300
- Registration Number
- NCT07025772
- Locations
- 🇺🇸
RESTORE Laboratory: Research on Emotion, Substance Use Treatment Outcomes, Rehabilitation, and Empowerment, Houston, Texas, United States
Smart Olfaction App to Reduce Relapse
- Conditions
- Nicotine Dependence
- Interventions
- Device: Ad Libitum Use followed by Instructed Use of the Inspire DeviceDevice: Instructed Use followed by Ad Libitum Use of the Inspire DeviceDevice: Smart-T Smoking Cessation App with the Inspire Device ConditionDevice: Smart-T Smoking Cessation App Without the Inspire Device ConditionDevice: Inspire Device
- First Posted Date
- 2025-06-05
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- University of Houston
- Target Recruit Count
- 132
- Registration Number
- NCT07007195
- Locations
- 🇺🇸
RESTORE Laboratory: Research on Emotion, Substance Use Treatment Outcomes, Rehabilitation, and Empowerment, Houston, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next
News
Scientists Develop Laser-Free Eye Surgery Alternative Using Electrical Current to Reshape Cornea
Researchers at Occidental College and UC Irvine have developed electromechanical reshaping (EMR), a laser-free alternative to LASIK surgery that uses electrical current to temporarily reshape the cornea.
University of Houston Develops First Spleen-Targeted Nanoparticle System for Lupus Treatment
University of Houston biomedical engineer Tianfu Wu has received a $1 million Department of Defense Impact Award to develop a novel spleen-specific drug delivery system for lupus treatment.
Fentanyl Vaccine Poised for Clinical Trials, Offering Hope in Opioid Crisis
A fentanyl vaccine developed at the University of Houston is set to enter clinical trials in mid-2025, aiming to prevent the opioid from reaching the brain.